Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
---|---|---|---|---|---|---|---|---|
BIOTECHNOLOGY VALUE FUND L P | 9.99% | $33.9M | 4.71M | BVF PARTNERS L P/IL | Dec 31, 2024 | |||
Nantahala Capital Management, LLC | 9.99% | 0% | $32.6M | $3.4M | 4.52M | +11.6% | Nantahala Capital Management, LLC | Dec 31, 2024 |
BARCLAYS PLC | 8.87% | 0% | $28.5M | 3.95M | 0% | Barclays PLC | Dec 31, 2024 | |
BALYASNY ASSET MANAGEMENT L.P. | 8.87% | $28.5M | 3.95M | Balyasny Asset Management L.P. | Dec 31, 2024 | |||
Soleus Capital Master Fund, L.P. | 7.3% | $24.2M | 3.35M | Soleus Capital Management, L.P. | Dec 31, 2024 | |||
HIRSCHMAN ORIN | 6.1% | $19.6M | 2.72M | Orin Hirschman | Dec 31, 2024 | |||
VANGUARD GROUP INC | 5.19% | $16.7M | 2.31M | The Vanguard Group | Dec 31, 2024 | |||
Stonepine Capital Management, LLC | 4.8% | $15.9M | 2.2M | Stonepine Capital Management, LLC | Dec 31, 2024 | |||
Alyeska Investment Group, L.P. | 2.1% | $7.21M | 1M | Alyeska Investment Group, L.P. | Dec 31, 2024 |
Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
---|---|---|---|---|---|
2025 Q1 | 90.2K | $544K | -$62.6K | $6.03 | 5 |
2024 Q4 | 33.9M | $175M | +$45.2M | $5.17 | 90 |
2024 Q3 | 26.6M | $80.4M | +$34.2M | $2.99 | 77 |
2024 Q2 | 14.5M | $43.3M | -$62.7M | $2.98 | 66 |
2024 Q1 | 16.9M | $199M | +$4.6M | $11.80 | 69 |
2023 Q4 | 16.7M | $136M | -$1.64M | $8.14 | 56 |
2023 Q3 | 16.7M | $136M | +$6.64M | $8.13 | 55 |
2023 Q2 | 16.1M | $120M | +$120M | $7.44 | 59 |